Within the event-based model (EBM), the probability of a biomarker event (biomarker event measure) is determined by a mixture model including patients and controls. In this work we used a novel mixture of Kernel Density Estimates (Firth, et al., Unpublished), for which a full manuscript is in preparation. Figure S1 shows the mixture model components and biomarker event measures for the non-network biomarkers included in EBM00 (left, larger group derived from all ADNIGO/2) and EBM0 (right, smaller group derived from The168 only), which highlights the similarities, and subtle differences, in biomarker distributions between the larger and smaller groups. In particular, the event probability (black line) for FDG appears earlier in the full cohort, with an inflection point at a c-score of ≈ 1 vs ≈ 2.5. Figure S2 shows the mixture model components and event probabilities for the non-network and network biomarkers included in EBM1 (hubs) and EBM2 (centrality and shortest paths).
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Within the event-based model (EBM), the probability of a biomarker event (biomarker event measure) is determined by a mixture model including patients and controls. In this work we used a novel mixture of Kernel Density Estimates (Firth, et al., Unpublished) , for which a full manuscript is in preparation. Figure S1 shows the mixture model components and biomarker event measures for the non-network biomarkers included in EBM00 (left, larger group derived from all ADNIGO/2) and EBM0 (right, smaller group derived from The168 only), which highlights the similarities, and subtle differences, in biomarker distributions between the larger and smaller groups. In particular, the event probability (black line) for FDG appears earlier in the full cohort, with an inflection point at a c-score of ≈ 1 vs ≈ 2.5. Figure S2 shows the mixture model components and event probabilities for the non-network and network biomarkers included in EBM1 (hubs) and EBM2 (centrality and shortest paths). Figure S1: Biomarker Event Measures (EBM00 and EBM0): normalised histograms, Kernel Density Estimate mixture-model components, and event probabilities for the non-network biomarkers included in (a) EBM00 (data from ADNIGO/2) and (b) EBM0 (data from The168, a subset of ADNIGO/2). Horizontal axis is c-score (z-score relative to controls). Figure S2: Biomarker Event Measures (EBM1, EBM2, EBM4): normalised histograms, Kernel Density Estimate mixture-model components, and event probabilities for biomarkers included in (a) EBM1 (nonnetwork + hub markers) and (b) EBM2 (non-network + centrality markers). EBM4 contains the union of these biomarkers. Abbreviations explained in the main article. Horizontal axis is c-score (z-score relative to controls).
